Technology Impact Award

This grant aims to support the development of highly innovative technologies that can ultimately be adopted by the research community at large and that will enable researchers to develop the next generation cancer immunotherapies that can be effective and personalized for each patient. Technologies may facilitate our understanding of the antigenic profile, cellular interplay, and mechanistic pathways within the tumor microenvironment that are essential for an effective anti-tumor response.

Funding: $1,000,000 total 

Duration: No fixed limit 

Research Authority due date: 8.11.17

LOI (required) due date: 15.11.17

Full proposal due date: 15.3.18